On June 9, Cerebras Systems declined 3.29% in regular trading, trading at approximately $229.64 per share, with trading volume of $239 million. The stock had surged in pre-market trading after multiple top-tier investment banks simultaneously initiated coverage with bullish ratings, but intraday profit-taking reversed those gains.

On the news front, several major Wall Street banks launched coverage on the same day: Citigroup initiated at Buy with a $340 price target, Barclays at Outperform with a $280 target, Morgan Stanley at Overweight with a $250 target, Wedbush at Outperform with a $270 target, Mizuho at Outperform, and Craig-Hallum at Buy with a $325 target. Morgan Stanley highlighted Cerebras's first-mover advantage in low-latency AI inference, projecting contracted revenue opportunities could reach $6 billion by 2028. The consensus average target price stands at $294.

Despite the institutional endorsement, the stock reversed lower as the prior catalyst of S&P index inclusion — effective May 25 — has been fully priced in, with sustained profit-taking pressure continuing. The company's post-IPO price-to-sales ratio remains far above industry averages, and the current high interest rate environment continues to weigh on richly valued growth names, amplifying downside pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)